Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Priority Review of 10 mg XARELTO to Reduce VTE Risk

americanpharmaceuticalreviewJune 29, 2017

Tag: VTE Risk , FDA , Priority Review

PharmaSources Customer Service